The Danish medtech company Evosep has developed a unique technology that can separate the proteins in a blood sample much faster than traditional solutions in the market.

With a venture investment from VF Venture in 2016, the company aim to develop the technology and the associated equipment. The technology can possible save time and provide more accurate test results, e.g. in the search for new medicine.

"Worldwide, over 2,000 protein analysis systems are sold annually and the number is increasing. Our technology increases the analysis speed significantly and our equipment is far more robust than the equivalent on the market""

- Christian Ravnsborg, General Manager and Head of Marketing in Evosep

About Evosep

Protein analysis technology
Equity from VF Venture in 2016